Agilent Technologies (NYSE:A) Inc., headquartered in Santa Clara, California, is a leading provider of scientific instruments, software, services and consumables for the entire laboratory workflow. Established in 1999 through the spinoff of Hewlett-Packard’s analytical instruments business, Agilent has grown into a global innovator in life sciences, diagnostics and applied chemical markets. The company’s offerings support a wide range of analytical and diagnostic applications, enabling customers to gain precise insights into the composition, structure and function of complex biological and chemical systems.
Agilent’s product portfolio spans chromatography and mass spectrometry systems, spectroscopy instruments, microarrays, cell analysis tools and automation platforms. Its CrossLab segment delivers services and consumables that help customers optimize instrument performance, from installation and validation to training and maintenance. The Diagnostics and Genomics group, bolstered by the 2012 acquisition of Dako, provides reagents and instruments for molecular pathology, companion diagnostics and genomic research. In 2019, the company further expanded its reach in life science instrumentation through the acquisition of BioTek Instruments, enhancing its capabilities in microplate readers, washers and automated liquid handling.
The company serves a diverse global customer base across pharmaceuticals, biotechnology, academia, food safety, environmental testing, forensics and electronics manufacturing. Agilent maintains a presence in over 30 countries, with manufacturing, R&D and support centers in North America, Europe and the Asia-Pacific region. Its instruments and solutions play a critical role in drug discovery, clinical diagnostics, environmental monitoring and quality control processes worldwide.
Under the leadership of President and Chief Executive Officer Michael R. McMullen, who joined Agilent in 2009 and was appointed CEO in 2014, the company has focused on advancing scientific discovery through strategic investments in R&D and targeted acquisitions. Agilent’s management team continues to prioritize innovation, operational excellence and customer-centric service to drive long-term growth and maintain its position at the forefront of analytical science.